COVID-19 Information Center


COVID-19 Situation Summary

  • Global case numbers may be viewed here.

  • U.S. case numbers may be viewed here.


General Resources and Documents

  • What you need to know about coronavirus disease 2019 (COVID-19)

    • ​​​COVID-19 is a new disease that causes respiratory illness in people and can spread from person to person. This virus was first identified during an investigation into an outbreak in Wuhan, China. A concise fact sheet provided by the U.S. CDC may be viewed here.


  • What to do if you are sick with COVID-19

    • If you are sick with COVID-19 or suspect you are infected with the virus that causes COVID-19, there are resources to help prevent the disease from spreading to people in your home and community. This information is available in both poster and video format.

  • White House Proclamation (issued January 31, 2020)

    • This proclamation concerns the entry restrictions of people who are suspected to be public health risk concerns due to the possibility of their carrying or being infected with the coronavirus. Read more ​


Recent News And Contributions to the Global Effort

  • The EU's Response to COVID-19 >>>

  • Denmark's supports the international fight against the coronavirus with DKK 8M >>>

  • Slovakia's contribution to the World Health Organization's fight against the coronavirus >>>

  • Norway supports efforts to combat COVID-19 outbreak >>>

  • New UK aid to help stop the spread of coronavirus around the world >>>

  • Japan commits US$10M to the outbreak response >>>

  • Bill and Melinda Gates Foundation commits up to US$100M to the Novel Coronavirus Response >>>


Recent Correspondence with Leading Health Professionals

Dr. Lincoln C. Chen, President of China Medical Board

Dr. Chen is dedicated to bringing world-class medical knowledge to China and emphasizes that cooperation and two-way exchanges between the U.S. and China is mutually beneficial. During the dialogue, he addresses three main questions: 1) how China could have responded more promptly to the outbreak, 2) how to implement a smoother and more efficient infectious disease monitoring and reporting system, and 3) how public health system should be further developed to protect health professionals during both emergencies and routine procedures. Read more

Dr. William A. Haseltine, Chairman of U.S.-China Health Summit; Chairman, President of ACCESS Health International

Dr. Haseltine utilizes his extensive experiences in both the medical and administrative fields to provide a fresh perspective on what can be done in China to improve the management of the outbreak. Some key points he discusses include the absence of readily available and developed prophylactic drugs to protect people during the early stages of infection, and the concerns of having a hospital-centered healthcare system in large countries. Read more


Guidance for Health Professionals

  • National capacities review tool for a novel coronavirus (nCoV) >>>

  • Clinical management of severe acute respiratory infection >>>

  • Home care for patients with suspected nCoV infection >>>

  • COVID-19 risk communication package for healthcare facilities: >>>

  • Advice on the Use of Masks >>>


Guidance for Laboratory Research

  • ​WHO interim guidance for laboratory testing >>>

  • WHO interim guidance for laboratory biosafety related to 2019-nCoV >>>
  • In-house developed molecular assays to diagnose 2019-nCoV

    • Charité, Berlin, Germany (17 January 2020): RT-PCR detection

    • Hong Kong University School of Public Health (23 January 2020): RT-PCR detection

    • China CDC (24 January 2020): Primer and Probes

    • National Institute of Infectious Diseases, Japan (24 January 2020): PCR and sequencing protocol

    • Ministry of Public Health, Thailand (updated 28 January 2020): PCR and sequencing protocol

    • US CDC (28 January 2020): RT-PCR Panel for Detection and Primer and Probes


Sources for Updated Research

  • BMJ >>>

  • Cambridge University Press >>>

  • U.S. Centers for Disease Control and Prevention >>>

  • Cochrane >>>

  • Elsevier >>>

  • European Centre for Disease Prevention and Control (ECDC) >>>

  • JAMA Network >>>

  • The Lancet >>>

  • New England Journal of Medicine >>>

  • Oxford University Press >>>

  • PLOS >>>

  • Springer Nature >>>

  • SSRN (Preprints) >>>

  • Wiley >>>

  • WHO >>>


WHO Appointed 2019-nCoV Referral Laboratories

Countries who have no testing capacity can send their samples to WHO appointed 2019-nCoV referral laboratories for testing. National 2019-nCoV laboratories with limited experience are encouraged to send the first five positives and the first ten negative samples to referral laboratories for confirmation.

  • Current list of WHO-appointed 2019-nCoV referral laboratories (Updated 10 February 2020) >>>

  • Shipping instructions for national laboratories with 2019-nCoV specimens that require testing (Updated 7 February 2020) >>>

  • Booking form for national laboratories (Updated 7 February 2020) >>>


Guidance for Management and Policy

  • Risk communication and community engagement inn response to the 2019-nCoV >>>

  • Management of travelers at points of entry >>>

  • Management in air transport >>>

  • Management in the maritime sector

    • Operational considerations for managing COVID-19 cases/outbreak on board ships >>>

    • Handbook for the management of public health events on board ships >>>

    • Handbook for the inspection of ships and issuance of ship sanitation certificates >>>

  • Global Surveillance of 2019-nCoV >>>

  • Resources for planning for mass gatherings


Related Topics

  • Middle East Respiratory Syndrome Coronavirus (MERS-CoV) >>>

  • Severe Acute Respiratory Syndrome (SARS) >>>